Research / ZS / Fundamental state Inspectable configuration
State dimensions Filing 0001713683-23-000059 General Corporate
Debt relative to revenue 27th Own-history percentile · N=11
Evidence method Level · gp.fundamentals.debt_to_revenue
272.41% · OPTIONAL · VALID
Capex intensity 28th Own-history percentile · N=18
Evidence method Level · gp.fundamentals.capex_revenue_ratio
6.27% · OPTIONAL · VALID
Operating cash generation 61th Own-history percentile · N=18
Evidence method Ratio · gp.fundamentals.operating_cash_flow + gp.fundamentals.revenue
25.90% · OPTIONAL · VALID
Revenue growth 19th Own-history percentile · N=16
Evidence method Yoy · gp.fundamentals.revenue
46.02% · CORE · VALID
Gross margin 0th Own-history percentile · N=20
Evidence method Level · gp.fundamentals.gross_margin
77.11% · CORE · VALID
Operating margin 90th Own-history percentile · N=20
Evidence method Level · gp.fundamentals.operating_margin
-13.31% · CORE · VALID
R&D intensity 50th Own-history percentile · N=20
Evidence method Ratio · gp.fundamentals.rnd + gp.fundamentals.revenue
22.12% · OPTIONAL · VALID
SBC intensity 45th Own-history percentile · N=20
Evidence method Level · gp.fundamentals.sbc_revenue_ratio
25.74% · OPTIONAL · VALID
As-filed lineage Fundamental state history Each observation is tied to the filing and facts available at that report date. Amendments remain separate.
History 34 states Self-history eligible
Oct 31, 2021 7/8 normalized Level 3 Jan 31, 2022 5/6 normalized Level 3 Apr 30, 2022 7/8 normalized Level 3 Jul 31, 2022 8/8 normalized Level 3 Oct 31, 2022 8/8 normalized Level 3 Jan 31, 2023 8/8 normalized Level 3 Apr 30, 2023 8/8 normalized Level 3 Jul 31, 2023 8/8 normalized Level 3 Oct 31, 2023 8/8 normalized Level 3 Jan 31, 2024 6/6 normalized Level 3 Apr 30, 2024 8/8 normalized Level 3 Jul 31, 2024 8/8 normalized Level 3 Oct 31, 2024 8/8 normalized Level 3 Jan 31, 2025 8/8 normalized Level 3 Apr 30, 2025 8/8 normalized Level 3 Jul 31, 2025 7/7 normalized Level 3 Oct 31, 2025 7/7 normalized Level 3 Jan 31, 2026 7/7 normalized Level 3 Apr 30, 2026 7/7 normalized Level 3 Jul 31, 2026 7/7 normalized Level 4 Period transition
What moved in the state? Balance Sheet Leverage Decreased
Previous 294.25%
Current 272.41%
Delta -21.85% Capex Intensity Increased
Previous 4.82%
Current 6.27%
Delta 1.45% Cash Generation Increased
Previous 23.09%
Current 25.90%
Delta 2.81% Growth Decreased
Previous 51.66%
Current 46.02%
Delta -5.64% Margin Decreased
Previous 77.40%
Current 77.11%
Delta -0.28% Profitability Increased
Previous -16.83%
Current -13.31%
Delta 3.52% R And D Intensity Decreased
Previous 22.13%
Current 22.12%
Delta -0.01% Sbc Intensity Decreased
Previous 28.31%
Current 25.74%
Delta -2.57% Self-history only Previous similar states Similarity compares compatible valid dimensions from this issuer's own point-in-time history. No market-return claim is attached.
Not enough compatible prior states for a transparent self-history match.
Research Graph
Related governed research Method Percentiles and historical matches use only observations available at each point in time. Missing dimensions remain missing. Public price outcomes and cross-market analogues are deliberately absent.